Biocon informs about press release

29 Dec 2017 Evaluate

Biocon has informed about Press Release titled ‘Biocon and Mylans Biosimilar Trastuzumab Receives Approval from ANVISA, Brazil Through Their Partner Libbs’.

The above information is a part of company’s filings submitted to BSE.

Biocon Share Price

380.05 -0.20 (-0.05%)
17-Feb-2026 13:42 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1716.85
Dr. Reddys Lab 1277.00
Cipla 1343.65
Zydus Lifesciences 905.15
Lupin 2241.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×